Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the ST14 gene broadens the understanding of ichthyosis-hypotrichosis syndrome.

Early diagnosis and tailored treatments are crucial for managing ichthyosis syndromes with hair abnormalities.

Lack of cystatin M/E causes thin hair and dry skin.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Possible link between COVID-19 and hair loss; more research needed.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Genetic mutations can cause hair growth disorders by affecting key genes and signaling pathways.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Some alopecia treatments might help treat COVID-19, but more research is needed.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Genetic mutations cause various hair diseases, and whole genome sequencing may reveal more about these conditions.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Some hair loss disorders are caused by genetic mutations affecting hair growth.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Corin helps control salt and sweat release in sweat glands.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.